Literature DB >> 9796886

Determinants of carotid artery wall thickening in young patients with Type 1 diabetes mellitus.

D Frost1, W Beischer.   

Abstract

To investigate associations between early atherosclerosis and possible risk factors for it in young patients with established Type 1 diabetes mellitus (DM), we measured the combined intima-media thickness (IMT) of the common carotid arteries with high resolution ultrasound in 310 young patients (age < or = 40 years, mean 27.9 +/- 6.5) with a diabetes duration > or = 2 years, and in two control groups of similar age (control 1:40 healthy subjects, control 2: 40 Type 1 DM recently diagnosed patients). Albumin excretion rate and lipids (total cholesterol and triglycerides) were measured and retinopathy and hypertension (systolic blood pressure > 140 or diastolic blood pressure > 90 mmHg) sought in the patients. Mean maximum IMT was 0.52 +/- 0.06 mm in control group 1 and 0.50 +/- 0.05 mm in control group 2 with a mean difference of 0.02 mm (95% CI: -0.01, 0.04). The more established Type 1 DM patients had a significantly greater IMT (0.57 +/- 0.13 mm, p < 0.001) than both control groups. In a subgroup analysis, patients with microvascular diabetic complications (n = 99) had a significantly greater IMT (0.63 +/- 0.17 vs 0.55 +/- 0.10 mm, p < 0.001) than those without (n = 211). In a multiple linear regression analysis with a significance level of < or = 0.10, the carotid artery IMT of our established diabetic patients was related to age, male gender, triglycerides and nephropathy, suggesting the latter as the main diabetes-specific risk for intima-media thickening in young Type 1 DM patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796886     DOI: 10.1002/(SICI)1096-9136(199810)15:10<851::AID-DIA660>3.0.CO;2-9

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus.

Authors:  Amy S Shah; Lawrence M Dolan; Thomas R Kimball; Zhiqian Gao; Philip R Khoury; Stephen R Daniels; Elaine M Urbina
Journal:  J Clin Endocrinol Metab       Date:  2009-09-01       Impact factor: 5.958

2.  Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home
Journal:  Diabetes Metab Syndr Obes       Date:  2011-01-19       Impact factor: 3.168

3.  Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats.

Authors:  Erik Salum; Mark Butlin; Jaak Kals; Mihkel Zilmer; Jaan Eha; Alberto P Avolio; Andres Arend; Marina Aunapuu; Priit Kampus
Journal:  Diabetol Metab Syndr       Date:  2014-05-20       Impact factor: 3.320

4.  Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy.

Authors:  Eelco van Duinkerken; Richard G Ijzerman; Nynke J van der Zijl; Frederik Barkhof; Petra J W Pouwels; Menno M Schoonheim; Annette C Moll; Jeannette Boerop; Alette M Wessels; Martin Klein; Frank J Snoek; Michaela Diamant
Journal:  Cardiovasc Diabetol       Date:  2014-03-12       Impact factor: 9.951

5.  The relationship between early atherosclerosis and endothelial dysfunction in type 1 diabetic patients as evidenced by measurement of carotid intima-media thickness and soluble CD146 levels: a cross sectional study.

Authors:  Sema Ciftci Dogansen; Aysen Helvaci; Mine Adas; Suzan Deniz Onal
Journal:  Cardiovasc Diabetol       Date:  2013-10-18       Impact factor: 9.951

6.  Nitric Oxide Gene Polymorphism is a Risk Factor for Diabetic Nephropathy and Atherosclerosis in Type 1 Diabetic Patients.

Authors:  Soha M Abd El Dayem; Ahmed A Battah; Abo El Maged El Bohy; Solaf Ahmed; Mona Hamed; Safa Nabil Abd El Fattah
Journal:  Open Access Maced J Med Sci       Date:  2019-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.